Pathway Therapeutics Garners $200,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=07be8fdf-a2a1-4436-b892-ac9b85c99f50&Preview=1 -
Date
11/30/2012 -
Company Name
Pathway Therapeutics -
Mailing Address
409 Illinois Street San Francisco, CA 94158 -
Company Description
Pathway Therapeutics is a clinical stage, privately held, pharmaceutical company developing differentiated and best in class isoform specific PI3-kinase (PI3K) inhibitors for oncology, inflammatory and respiratory diseases. -
Website
http://www.pathwaytx.com -
Transaction Type
Debt -
Transaction Amount
$200,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
